Patient Recruitment for Oncology Studies: Improving Your Probability of Success

Publish Date:
March 7, 2013
Connie Wierman, Biopharmaceutical Development

The oncology pipeline is full to overflowing. In 2012, there were more than 1,000 new oncology drugs in development — most in early phase — with a growing complexity of protocols and an increasing number of targeted therapies. This situation creates increased pressure on patient recruitment for oncology trials and escalates the time and cost involved. It also puts pressure on investigator sites to be able to manage new technologies such as pharmacogenomics, CT/PET imaging and mutation testing. In a career spanning more than 25 years, with much of it specific to oncology, Connie Wierman is a respected authority on the subject. In this informative video, she looks at the challenges presented in mounting oncology trials as well as the practical considerations necessary to make them succeed.

File size: 1.68GB | Format: MP4 | Length: 42.36MINS

Depending on your operating system and type of Web browser the files may take a long time to download.